RXRX
Recursion Pharmaceuticals Inc.
$5.50
-$0.02(-0.36%)
50
Overall
60
Value
41
Tech
50
Quality
Market Cap
$2.54B
Volume
38.43M
52W Range
$3.79 - $12.36
Target Price
$6.47
EPS Estimates Overview
| Current Quarter | $-0.38 | Next Quarter | $-0.28 |
| Current Year | $-1.53 | Next Year | $-1.16 |
| QoQ Growth | +26.3% | YoY Growth | +24.2% |
| 3Y EPS CAGR | -4.3% | Target Price | $6.47 |
| Consensus | Buy | Upside | +17.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXRX | $5.50 | -0.4% | 38.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Recursion Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW